Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
550.7 USD | +3.78% |
|
+4.06% | +16.79% |
15/07 | Truist Securities Adjusts Price Target on Elevance Health to $620 From $600, Maintains Buy Rating | MT |
11/07 | 50 billion dollars - What US insurers pocketed for fictitious illnesses | ![]() |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.79% | 12TCr | |
+13.63% | 9.41TCr | |
-13.46% | 4.63TCr | |
-7.68% | 3.52TCr | |
-16.33% | 1.66TCr | |
-19.34% | 276.43Cr | |
+14.63% | 171.7Cr | |
+81.70% | 78Cr |
- Stock Market
- Equities
- ELV Stock
- News Elevance Health, Inc.
- Transcript : WellPoint Inc. Presents at 31st Annual JPMorgan Healthcare Conference, Jan-08-2013 09